IL28401A - Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them - Google Patents
Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing themInfo
- Publication number
- IL28401A IL28401A IL28401A IL2840167A IL28401A IL 28401 A IL28401 A IL 28401A IL 28401 A IL28401 A IL 28401A IL 2840167 A IL2840167 A IL 2840167A IL 28401 A IL28401 A IL 28401A
- Authority
- IL
- Israel
- Prior art keywords
- general formula
- manufacture
- same meaning
- process according
- acid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 title description 2
- -1 Arylsulfonyl ureas Chemical class 0.000 title 1
- 235000013877 carbamide Nutrition 0.000 title 1
- 238000000034 method Methods 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 7
- 229940124530 sulfonamide Drugs 0.000 claims description 6
- 150000003456 sulfonamides Chemical class 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- BUXTXUBQAKIQKS-UHFFFAOYSA-N sulfuryl diisocyanate Chemical compound O=C=NS(=O)(=O)N=C=O BUXTXUBQAKIQKS-UHFFFAOYSA-N 0.000 claims description 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- XIWRCSVXKPGGAJ-UHFFFAOYSA-N 1-(5-tert-butyl-2-phenylpyrazol-3-yl)-3-(4-chlorophenyl)urea Chemical compound C=1C=CC=CC=1N1N=C(C(C)(C)C)C=C1NC(=O)NC1=CC=C(Cl)C=C1 XIWRCSVXKPGGAJ-UHFFFAOYSA-N 0.000 claims 1
- 241000282320 Panthera leo Species 0.000 claims 1
- 125000002015 acyclic group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 230000000881 depressing effect Effects 0.000 claims 1
- 230000000994 depressogenic effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 9
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/59—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
Arylsulfonyl their manufacture and pharmaceutical compositions containing them SPARAMEDICA This invention to novel sulfonamides and to a process for the manufactwe In one the novel sulfonamides of the invention are sul onylurea derivatives of the general formul 1 2 wherei represents hydroge R represents 1 or R and R taken together represent represents a phenyl radical bearing one or lower lower o lower ethyl or a or containing heterocyclic and n is 3 or The compounds of the invention may be manufactured by a process comprising reacting a reactive derivative of a sulfonylcarbamlc acid of the general ormula o a sulfonylisocyanate of the general formula solvents which do not contain hydroxy such as halogenated hydrocarbons such as or In a preferred embodiment of process variant there is used a compound of the general formula in which Z presents the a sulfonamide as an alkali is reacted with zole in a suitable anhydrous organic solvent of the kind tioned The acid imidazolide which is formed is allowed to react in situ with r or When a cyclic is the keto group in the reaction product obtained can be subsequently reduced to the hydroxyl This can be effected in a manner known per for by treatment with a complex metal hydride such as sodium isomers obtained in the reduction can if be separated according to methods known per se by crystallization by On the other a hydroxy group contained in the reaction product can be to the keto group in a manner known per se by means of chromic ί The starting compounds of the above formula IV can be by reaoting a sulfonylcarbamio acid derivative o a sulfonylisocyanate with a or 50 ml of treated at with g of The reaction mixture was at for a further 20 minutes then treated with g cls The reaction was allowed to warm up to room stirred for a further 2 hours and evaporated in The residue taken up in 60 ml of caustic soda and the solution was with The ethereal was extracted 40 ml of caustic soda and the combined aqueous j were made with hydrochloric The solution was extracted with acetic ester and working up of ester extract yielded melting point Example 2 Following a similar procedure to that described in Example 1 from acid zolide in situ from and there was tained melting point Example 3 Following a similar prooedure to that described in Example from and melting Exam le 4 A mixture of 7 8 g of acid ethyl g of and ml of absolute pyridine was heated at for hours in the absence of The oily reaction product was dissolved 100 ml of caustic soda and after extraction with aqueous phase was saturated with C02 and The i jfiltrate was acidified with acetic acid and the which separated out crystallized on standing and was recrystallized ester The product decomposed above ί Example 5 i j 8 g of oxazolidinone in 150 ml of caustic soda were heated to reflux for about After the reaction solution was acidified with hydrochloric The reaction which separated out as an oil crystallized on standing and i reprecipitated by dissolving in soda solution and ί fication of the solution with hydrochloric The 1 t melted at The starting material was manufactured as melting Example 10 A solution of g of in 400 ml of acetone was treated with an aqueous chromic acid solution g of per 100 up to the positive The mixture was then treated with about 500 ml of water in order to dissolve the chromium salt and acetone was evaporated in The aqueous residue was with and extract washed with salt dried and evaporated There was obtained oluenesulfonyl melting point Example 11 j To a solution of 5 75 S of trans 50 ml of absolute after the addition of ml of there were slowly with and 17 ml of standing for 2 days at room the solvent evaporated the residue dissolved in ml of On saturation of the solution with there was precipitated a brown resin from which the mother liquor was After extraction with the aqueous solution was insufficientOCRQuality
Claims (1)
1. A compound of the general formula 1 wherein R represents hydroge R represents o taken together represent R represents phenyl radical bearing one or more lowe alkylthio or lower ethyl or a or heterocyclic grou and n is 3 or urea 16 A process for the manufacture of hovel sulfonamides the general formula I in Claim wherein a reactive derivative sulfonylearbamic acid the general formula or a sulfonylisocyanate of the general formula in which formulae has the same meaning in Claim is acted with cyclohexanone or A process according to Claim wherein a pound of general formula wherein has the same meaning as in 1 and is lower lower or is used as a reactive earbamic acid A rocess accordin to Claim 1 or 1 where n 18 which formulae and n have the same meaning as in Claim is treated with an Process for the preparation of sulfonamides I in 1 as hereinbefore particularly especially with to the Process for the manufacture of preparations having sugar depressing characterized in that a amide of genera formula I is as active s with therapeuticall compatible olid or liquid used in blood sugar depressant containin a sulfonamide of the general formula I in Claim and a A compound of the general formula I in Claim 1 whenever prepared by a process according to any one of Claims 13 to 20 by an obvious ohemical equivalent whenever prepared by a process according to any one of Claims 13 to or by an obvious chemical equivalent insufficientOCRQuality
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1136566A CH500176A (en) | 1966-08-08 | 1966-08-08 | Sulphonamides and process for the manufacture thereof |
| CH787469A CH509991A (en) | 1966-08-08 | 1966-08-08 | Sulphonamides and process for the manufacture thereof |
| CH787569A CH509992A (en) | 1966-08-08 | 1966-08-08 | Process for the preparation of sulfonamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL28401A true IL28401A (en) | 1971-04-28 |
Family
ID=27175874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL28401A IL28401A (en) | 1966-08-08 | 1967-07-26 | Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5516575B1 (en) |
| BE (1) | BE702280A (en) |
| CH (2) | CH509992A (en) |
| DE (1) | DE1668199B2 (en) |
| DK (1) | DK122761B (en) |
| ES (1) | ES343910A1 (en) |
| FR (1) | FR7148M (en) |
| GB (3) | GB1147403A (en) |
| IL (1) | IL28401A (en) |
| NL (1) | NL6710676A (en) |
| SE (1) | SE334354B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20221627A1 (en) | 2015-02-16 | 2022-10-19 | Univ Queensland | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF THESE |
| BR112019024831A2 (en) | 2017-05-24 | 2020-06-09 | The University Of Queensland | compound, salt, solvate or prodrug, pharmaceutical composition, method of treating or preventing a disease, method of inhibiting nlrp3 |
| PT3661925T (en) | 2017-07-07 | 2022-01-31 | Inflazome Ltd | Novel sulfonamide carboxamide compounds |
-
1966
- 1966-08-08 CH CH787569A patent/CH509992A/en not_active IP Right Cessation
- 1966-08-08 CH CH787469A patent/CH509991A/en not_active IP Right Cessation
-
1967
- 1967-07-12 SE SE10481/67A patent/SE334354B/xx unknown
- 1967-07-26 IL IL28401A patent/IL28401A/en unknown
- 1967-07-29 DE DE1967H0063446 patent/DE1668199B2/en active Granted
- 1967-08-02 NL NL6710676A patent/NL6710676A/xx unknown
- 1967-08-04 GB GB35845/67A patent/GB1147403A/en not_active Expired
- 1967-08-04 BE BE702280D patent/BE702280A/xx unknown
- 1967-08-04 GB GB50521/68A patent/GB1147405A/en not_active Expired
- 1967-08-04 GB GB50520/68A patent/GB1147404A/en not_active Expired
- 1967-08-07 DK DK401867AA patent/DK122761B/en unknown
- 1967-08-07 ES ES343910A patent/ES343910A1/en not_active Expired
- 1967-08-08 JP JP5054967A patent/JPS5516575B1/ja active Pending
- 1967-08-08 FR FR117192A patent/FR7148M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1147403A (en) | 1969-04-02 |
| CH509991A (en) | 1971-07-15 |
| CH509992A (en) | 1971-07-15 |
| SE334354B (en) | 1971-04-26 |
| FR7148M (en) | 1969-08-04 |
| GB1147405A (en) | 1969-04-02 |
| DE1668199A1 (en) | 1971-09-02 |
| JPS5516575B1 (en) | 1980-05-02 |
| ES343910A1 (en) | 1968-10-01 |
| BE702280A (en) | 1968-02-05 |
| NL6710676A (en) | 1968-02-09 |
| DK122761B (en) | 1972-04-10 |
| DE1668199B2 (en) | 1976-06-24 |
| GB1147404A (en) | 1969-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2554816A (en) | Heterocyclic sulfonamides and methods of preparation thereof | |
| US2595334A (en) | Benzothiazolesulfonamides and method of preparing the same | |
| IL28401A (en) | Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them | |
| US2455894A (en) | Production of 1-mono-and 1, 2-disubstituted-3-cyanoguanidines | |
| US2072348A (en) | Chlorinated trialkyl amines and method of producing | |
| DE949742C (en) | Process for the preparation of N-allyl normorphine from normorphine and allyl halide | |
| US3325515A (en) | Coumarin derivatives and their preparation | |
| US2603649A (en) | Heterocyclic sulfonamides and method of preparing the same | |
| US2740781A (en) | 3, 26-dihydroxy-16, 22-imino-5-cholestenes, 3, 26-dihydroxy-16, 22-imino-5, 16, 20(22)-cholestatrienes and derivatives thereof | |
| US2664428A (en) | delta-17 alpha-hydroxy-3,20-diketo-pregnen-21-als | |
| NO122920B (en) | ||
| US2863873A (en) | Esters of nicotinic acid | |
| US3350407A (en) | Sulfur containing pyrazole derivatives | |
| IL22148A (en) | Benzenesulfonyl ureas | |
| NO133892B (en) | ||
| US3234210A (en) | New ureas and process for preparing same | |
| US3444167A (en) | Process for the production of thiamine derivatives | |
| US3068238A (en) | 3-cyano, 4-hydroxy-1, 2, 5-thiadiazole, derivatives and process | |
| US3183232A (en) | O, s-disubstituted thiol-type thiamines | |
| US2673873A (en) | Basic esters of 9, 10-dihalogenated 9, 10-dihydro-9, 10-ethanoanthracene-11-carboxylic acids and their derivatives | |
| SU436492A3 (en) | METHOD FOR OBTAINING DERIVATIVES OF PICOLINE WASTE ACIDS | |
| US3152123A (en) | Process for the preparation of benzo- | |
| AT277277B (en) | PROCESS FOR MANUFACTURING NEW SULFONYL URENE DERIVATIVES | |
| US3322760A (en) | 6-(substituted-amino)-1-tetralones | |
| US3468889A (en) | O-and/or s-nicotinoyl diacylthiamines and acylation process for preparing the same |